In contrast to the ER and/or PR+/HER2- subgroup, underweight breast cancer patients exhibit significantly worse OS and BCSS compared with normal and obese BMI category breast cancer patients in the ER and PR-/HER2+ subgroup. This evidence concerns the gene ESR1 and breast carcinoma.